-
公开(公告)号:EP3622813B2
公开(公告)日:2024-06-19
申请号:EP19207050.6
申请日:2010-07-07
IPC分类号: A01K67/027 , C07K16/00 , C07K16/46 , C12N15/85 , C12N15/90
-
公开(公告)号:EP3607073B1
公开(公告)日:2024-06-05
申请号:EP18781685.5
申请日:2018-04-03
IPC分类号: C12N15/63 , A01K67/027 , C12Q1/68
-
公开(公告)号:EP4436982A1
公开(公告)日:2024-10-02
申请号:EP22817389.4
申请日:2022-11-23
申请人: Novartis AG
IPC分类号: C07K14/005 , C12N7/00 , C12N15/86
-
公开(公告)号:EP4423258A1
公开(公告)日:2024-09-04
申请号:EP22783583.2
申请日:2022-09-26
发明人: TIBERI, Luca , ANTONICA, Francesco
-
公开(公告)号:EP4389764A3
公开(公告)日:2024-08-14
申请号:EP24161280.3
申请日:2013-11-05
申请人: Regeneron Pharmaceuticals, Inc. , Yale University , Institute for Research in Biomedicine (IRB)
发明人: FLAVELL, Richard , STROWIG, Till , MANZ, Markus G. , BORSOTTI, Chiara , DHODAPKAR, Madhav , MURPHY, Andrew J. , STEVENS, Sean , YANCOPOULOS, George D.
IPC分类号: A01K67/027 , C07K14/54 , C07K14/535 , C12N5/10
CPC分类号: C07K14/535 , C07K14/5403 , C07K14/5412 , A01K2217/05220130101 , A01K2217/07220130101 , A01K2217/1520130101 , A01K2227/10520130101 , C07K14/524 , A01K2267/0120130101 , A01K67/0278 , A61K49/0008 , C12N5/10
摘要: Genetically modified non-human animals are provided that may be used to model human hematopoietic cell development, function, or disease. The genetically modified non-human animals comprise a nucleic acid encoding human IL-6 operably linked to an IL-6 promoter. In some instances, the genetically modified non-human animal expressing human IL-6 also expresses at least one of human M-CSF, human IL-3, human GM-CSF, human SIRPa or human TPO. In some instances, the genetically modified non-human animal is immunodeficient. In some such instances, the genetically modified non-human animal is engrafted with healthy or diseased human hematopoietic cells. Also provided are methods for using the subject genetically modified non-human animals in modeling human hematopoietic cell development, function, and/or disease, as well as reagents and kits thereof that find use in making the subject genetically modified non-human animals and/or practicing the subject methods.
-
16.
公开(公告)号:EP4401782A1
公开(公告)日:2024-07-24
申请号:EP22870560.4
申请日:2022-09-12
发明人: JOHN, Varghese , CAMPAGNA, Jesus
-
公开(公告)号:EP4395542A1
公开(公告)日:2024-07-10
申请号:EP22865338.2
申请日:2022-08-26
IPC分类号: A01K67/027 , C12N15/85
-
公开(公告)号:EP4389211A2
公开(公告)日:2024-06-26
申请号:EP24157959.8
申请日:2020-04-30
IPC分类号: A61P9/10
CPC分类号: C07K14/47 , A61K38/1709 , C12N2750/1414320130101 , A01K2217/05220130101 , A01K2227/10520130101 , A01K2267/039320130101 , A61K48/005 , A01K2207/2020130101
摘要: A protein selected from the group consisting of Chrdl1, Fam3c, Fam3b and a fragment thereof, or a polynucleotide encoding therefor, for use in treating or reducing the risk of heart disease.
-
公开(公告)号:EP4370154A1
公开(公告)日:2024-05-22
申请号:EP22842837.1
申请日:2022-07-14
发明人: WANG, Wenjing , MAO, Xiaobo , RIANI, Yemima , LIU, Yuqing , KUMBHAR, Ramhari
IPC分类号: A61K39/395 , A61P25/16 , A61P25/28 , C07K14/47 , C07K16/18 , C12N15/864
-
公开(公告)号:EP4358707A1
公开(公告)日:2024-05-01
申请号:EP22829129.0
申请日:2022-06-21
发明人: SAKURAI, Kumi , TRAN, Anne Qiu
IPC分类号: A01K67/027 , C12N15/11 , C12N15/85 , C12N15/87 , C12Q1/6897
-
-
-
-
-
-
-
-
-